Gold Price Hits Two-Month High as Investors Await US Inflation Data 
Japan Executives Warn Weak Yen and Currency Volatility Threaten Economy 
Asian Stocks Rise as Weak US Jobs Data Eases Fed Rate Hike Fears 
Oil Prices Rise as Hormuz Reopening Remains Uncertain 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
Yes, government influences wages – but not just in the way you might think 
Nvidia Secures $500 Billion AI Infrastructure Push With Wall Street Giants 
Iran-Oman Near Strait of Hormuz Deal as Shipping Tensions Persist 
6 simple questions to tell if a ‘finfluencer’ is more flash than cash 
European Stocks Flat as Oil Prices Rise, US CPI in Focus 
Want to cut your energy bills? Here’s how five experts are doing it 
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
Can your cat recognise you by scent? New study shows it’s likely 
The American mass exodus to Canada amid Trump 2.0 has yet to materialize 
Yen Stabilizes After Intervention Slide as Australian Dollar Hits Eight-Week High 
BioNTech SE, a Mainz-based German biotech firm, confronts a homegrown lawsuit seeking compensation for purported COVID-19 vaccine side effects. The initial case, scheduled for court on June 12, is expected to precipitate nationwide litigation.
BioNTech is set to attend the first court hearing on Monday, June 12. It will go to court to defend itself from the first case filed by a German woman who allegedly suffered from side effects after receiving her COVID-19 jab. She is seeking damages, and more cases are expected to be filed across the country after this.
According to Reuters, the plaintiff is suing the biotech firm and asking for at least €150,000 or about $161,500 in damages. The regional court in Hamburg said that in her lawsuit, the woman said the amount is for bodily harm and other material damages that were not specified.
For this case, she is being represented by Rogert & Ulbrich law firm. She claimed that after the jab, she suffered from pains in the upper part of her body, developed a sleeping disorder, fatigue, and swollen extremities. Her lawyer, Tobias Ulbrich, told the publication that will challenge the assessment made by European Union regulators and the vaccine assessment bodies in Germany that said the BioNTech vaccine has positive benefits.
In any case, it was mentioned that under German pharmaceutical law, drug or vaccine makers are only liable to give compensation for side effects if medical science shows that their products bear incorrect information or have caused disproportionate harm commensurate to their benefits.
With this, BioNTech believes that after a careful review and consideration of the case, it concluded that the lawsuit holds no merit. It also noted that the same vaccine was already received by some 1.5 billion people around the world, including more than 64 million Germans.
Meanwhile, despite BioNTech’s statements, Financial Times reported that the law firm representing the woman insisted that the burden of proof and the possible compensation is lower in Germany. Thus, it is confident that their case against BioNTech is strong.
Photo: Mat Napo/Unsplash
